Jason Glaw, PhD, is currently the Global Market Access and Pricing Director for Early Oncology Assets at AstraZeneca. Jason's previous roles at AstraZeneca include US Oncology Pipeline Access Director and various leadership positions focused on market access strategy in immuno-oncology. Prior to working at AstraZeneca, Jason held consulting positions at The Advisory Board Company and The Amundsen Group. Jason also gained research experience as a Post-Doctoral Scientist and Graduate Student at the University of Virginia, where they earned a PhD.
This person is not in any teams
This person is not in any offices